Alcoholic liver disease: pathogenesis and new targets for therapy.
about
Aberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injuryNew treatment options for alcoholic hepatitisA Mechanistic Review of Mitophagy and Its Role in Protection against Alcoholic Liver DiseaseEthanol-induced oxidant stress modulates hepatic autophagy and proteasome activityAlcoholic liver disease: pathogenesis, management, and novel targets for therapyAlcoholic and non-alcoholic steatohepatitisNew advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseasesAbsence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed miceNon-invasive diagnosis of alcoholic liver disease.Diagnosis of alcoholic liver disease.New therapeutic targets in alcoholic hepatitis.Fibrogenesis in alcoholic liver disease.CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitisNrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.Expression of CYP2E1 and CYP2U1 proteins in amygdala and prefrontal cortex: influence of alcoholism and smoking.Transgenic mouse models for alcohol metabolism, toxicity, and cancer.Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activationHerbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in MiceOxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence.Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesisCell death and cell death responses in liver disease: mechanisms and clinical relevanceHuman alcohol-related neuropathology.Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.Alcoholic hepatitis: Can we outwit the Grim Reaper?Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in miceMacrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis.Effects of Linderae radix extracts on a rat model of alcoholic liver injuryPathogenesis and Management of Alcoholic Liver Disease.Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury.Epidemiology and surveillance of hepatocellular carcinoma.Mouse model of chronic and binge ethanol feeding (the NIAAA model)KASL clinical practice guidelines: management of alcoholic liver diseaseTlr4-mutant mice are resistant to acute alcohol-induced sterol-regulatory element binding protein activation and hepatic lipid accumulation.LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic HepatitisHuman and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
P2860
Q26741179-27B9CB0A-F9CA-40AE-B76E-A38ACE29F560Q26751402-622AC377-6A42-441C-9D52-94CF02C8E6DBQ26778940-5A9434E3-3233-4321-8E95-4997A704D367Q26852284-E58E82D4-91ED-4392-866A-03F157C2EC16Q26861620-6495F2F0-F5AF-4BD0-BEAF-95252881FE54Q27000153-F74A199F-E2A5-436A-AA3A-7BAB72BA04C9Q27026399-510263E7-8338-464C-A593-B064EF24A31FQ28240106-CE9D0104-1497-441C-9989-7DD8D0B6B282Q30427485-F2C910AE-E435-4618-9545-908DC4C4FF84Q30431186-AB391586-1F9A-43AC-9D22-4C76A6979696Q33757267-C71A4D49-2699-40F4-A191-DED0D42682A1Q33845463-8AEE52DD-D2A2-47CA-B928-4067BCE28E2FQ33882408-8B9AE2D0-C591-48C0-A55F-17DB01CCCDEFQ34017968-3542FC4E-3C1C-49CA-9D1A-652E9A172DC7Q34471582-04C1CBEA-7E61-4CD6-9F26-82ED210B5FC9Q35069133-0F2BA712-0488-468A-AA04-918752F10FF0Q35147488-B4E7426A-2A9B-4998-B744-96EF2E0A9530Q35224555-648CA5B8-58A1-4BE8-8976-D77968458315Q35675145-C43FDC07-BBCB-467B-9274-D1848E7E0B19Q35691565-A57FABCD-2C20-479C-8EB3-0BC3CCEE4452Q35816465-31EE11DA-93B5-41CE-B5E8-9D3F843D4865Q35874927-73B6163C-9C22-4616-8471-ABE032DE19F0Q35915822-6B685347-4108-4B17-93BE-21E353A1FC46Q35938040-EE8B02EA-BCF5-4A90-9E51-5345B77FD90AQ35940260-C4162E53-5835-4DA5-BD2F-441A445A86F8Q35977791-E5DCB1A4-1FC4-4290-BF89-8CA8C609384BQ35995574-B84BF512-A9AA-483E-ADB1-6A606ADB949DQ36096110-D6CA7499-4818-4F10-A7C5-BF4A79EE168EQ36287836-A1EC8BD5-8994-4A22-8726-27B0F4520187Q36684985-F369458F-5D45-468D-9744-9DC221BC4F79Q36954136-531F3633-435A-4219-8E17-0C61BAAC0819Q37011836-43EF7205-2A76-454C-9AAC-EC95854B2317Q37029804-B066E49E-36AD-4AB0-BF8D-5C331BED2EC1Q37059261-1C911BD3-713A-4E34-86B3-E13769B8B297Q37105532-CD208C89-2420-4177-863A-57D86C0B0F23Q37210744-0A562184-39EA-44D0-9E26-5EAD68C659BBQ37229858-1B60D7C4-357D-4EBC-825F-A49C00819B86Q37257762-E53AD6C6-54C6-4EA6-B26E-B02C7B14D6FFQ37345576-726AA63F-B0BA-4A6B-8A49-E6D3390456C2Q37424578-565DC87A-7EBC-4532-BE62-91AF4CFD5AF9
P2860
Alcoholic liver disease: pathogenesis and new targets for therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alcoholic liver disease: pathogenesis and new targets for therapy.
@en
Alcoholic liver disease: pathogenesis and new targets for therapy.
@nl
type
label
Alcoholic liver disease: pathogenesis and new targets for therapy.
@en
Alcoholic liver disease: pathogenesis and new targets for therapy.
@nl
prefLabel
Alcoholic liver disease: pathogenesis and new targets for therapy.
@en
Alcoholic liver disease: pathogenesis and new targets for therapy.
@nl
P2860
P1476
Alcoholic liver disease: pathogenesis and new targets for therapy.
@en
P2093
José Altamirano
Ramón Bataller
P2860
P2888
P304
P356
10.1038/NRGASTRO.2011.134
P407
P577
2011-08-09T00:00:00Z